ENT (Ear, Nose and Throat) and Bronchoscopy devices market comprises of a wide array of medical devices such as ENT powered instruments and radiofrequency devices, ENT hand instruments, endoscopes, bronchial stents, bronchial flexible scope and airway stents. These devices are used in a number of surgical procedures and treatment associated with ENT and lung diseases such as myringotomy, stapedectomy, tonsillectomy, internal biopsy and bronchial stenting. These surgical procedures are used in the treatment of a variety of diseases such as acute oitis media, eustachian tube dysfunction, conductive hearing loss and malignant and benign tracheobronchial stenosis. ENT powered instruments are used in a variety of ENT surgeries and facilitate better precision, surgical access, safety and speed. An endoscope is a device used to examine the interior surfaces of an organ inside the body. An endoscope encompasses a light and a video camera enabling doctors to see images and recording on the screen. In ENT endoscopes are used to look into nasal & sinus cavities and vocal cords and other throat tissues while in lung diseases it is used to look through airway of lungs and help in taking tissue sample.
The global ENT and bronchoscopy devices market is segmented broadly into ENT device market and Bronchoscope device market. The ENT device market is further segmented into powered ENT instruments market, ENT hand instruments market, ENT endoscope device market and ENT radio frequency & ultrasonic device market. The bronchoscopy device market is segmented into bronchial stent market, bronchial forceps & transbronchial aspiration needles market and bronchial hand instruments market.
The market for ENT and Bronchoscopy market is predicted to grow under the influence of increasing incidences of ENT and lung diseases worldwide such as chronic obstructive pulmonary diseases (COPD), sinusitis and otitis media, increasing habit of smoking and technological advancements leading to less invasive procedures such as radio frequency and powered instruments. WHO (World Health Organization) reports that COPD is the 4th leading cause of death worldwide and is expected to hold 3rd position by 2020 and it was reported that 64 million people were suffering from COPD worldwide in the year 2004. Geographically North America and Europe are leading the way in the market respectively with a combined market share accounting for more than 60% of the total market value. Major Asian regions are predicted to face aging population crisis in coming years leading to increased ENT and lung diseases that will drive the market growth.
Some of the market players in this industry are Boston Scientific Corporation, Carl Zeiss AG, Medtronic Inc., Lumenis Ltd., Meditech, Olympus Corporation and Broncus Technologies, Inc.
Request for Broucher @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1477